← Back to Analyst Consensus 
TNYA Buy
Tenaya Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 11, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Mar 12, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Dec 18, 2025 | Canaccord Genuity | maintain | Buy → Buy | $5 | 48% |
| Dec 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $3 | 44% |
| Dec 12, 2025 | Chardan Capital | maintain | Buy → Buy | $8 | 47% |
| Nov 10, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| Sep 2, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 27, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Aug 7, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| May 9, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| Apr 25, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 31, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Mar 13, 2025 | Canaccord Genuity | maintain | Buy → Buy | $6 | 48% |
| Mar 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $5 | 54% |
| Mar 12, 2025 | Chardan Capital | maintain | Buy → Buy | $9 | 47% |
| Mar 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Feb 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Jan 14, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Dec 18, 2024 | Chardan Capital | maintain | Buy → Buy | $18 | 47% |
| Dec 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Nov 26, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Nov 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Nov 7, 2024 | Chardan Capital | maintain | Buy → Buy | $18 | 47% |
| Oct 18, 2024 | Canaccord Genuity | maintain | Buy → Buy | $16 | 48% |
| Oct 18, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Jul 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Jun 10, 2024 | William Blair | initiate | — → Outperform | $0 | 48% |
| May 16, 2024 | Canaccord Genuity | maintain | Buy → Buy | $16 | 48% |
| May 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Mar 21, 2024 | Chardan Capital | reiterate | Buy → Buy | $20 | 47% |
| Mar 20, 2024 | Canaccord Genuity | maintain | Buy → Buy | $18 | 48% |
| Mar 19, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Nov 30, 2023 | Leerink Partners | initiate | — → Outperform | $7 | 51% |
| Oct 9, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Aug 14, 2023 | Chardan Capital | reiterate | Buy → Buy | $23 | 47% |
| Aug 11, 2023 | Canaccord Genuity | maintain | Buy → Buy | $17 | 48% |
| Aug 10, 2023 | Morgan Stanley | maintain | Overweight → Overweight | $14 | 54% |
| Aug 10, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| May 12, 2023 | Chardan Capital | maintain | Buy → Buy | $23 | 47% |
| May 11, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $18 | 44% |
| Mar 9, 2023 | Chardan Capital | maintain | — → Buy | $24 | 47% |
| Mar 9, 2023 | HC Wainwright & Co. | maintain | — → Buy | $18 | 44% |
| Jan 24, 2023 | Morgan Stanley | maintain | — → Overweight | $13 | 54% |
| Nov 11, 2022 | Chardan Capital | maintain | — → Buy | $28 | 47% |
| Nov 8, 2022 | Canaccord Genuity | initiate | — → Buy | $21 | 48% |
| Aug 11, 2022 | Chardan Capital | maintain | — → Buy | $30 | 47% |
| Jun 15, 2022 | HC Wainwright & Co. | initiate | — → Buy | $25 | 44% |
| May 17, 2022 | Morgan Stanley | maintain | — → Overweight | $15 | 54% |
| Aug 24, 2021 | Cowen & Co. | initiate | — → Outperform | $0 | — |
| Aug 24, 2021 | Morgan Stanley | initiate | — → Overweight | $31 | 54% |
| Aug 24, 2021 | Chardan Capital | initiate | — → Buy | $37 | 47% |
Price Target Trend
Apr 25, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days